The Royal Wolverhampton Hospitals Nhs Trust
Clinical trials sponsored by The Royal Wolverhampton Hospitals Nhs Trust, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Porcine collagen implant could help avoid corneal transplants Results expected Dec 2026 (estimated)
- The hidden price tag of kidney injury after heart surgery Results expected Apr 2027 (estimated)
- UK launches first national vitiligo registry to monitor treatment safety Results expected May 2027 (estimated)
- New app aims to simplify feeding tube care at home Results expected Jun 2027 (estimated)
- New device aims to stop surgical tools being left inside patients Results expected Jun 2027 (estimated)
-
New gel aims to stop bleeding in kidney surgery – but study never started
Disease control CancelledThis study planned to test a material called PuraBond that helps stop bleeding during robotic surgery for kidney cancer. The goal was to see if it works safely and helps the kidney heal. However, the study was withdrawn before any participants were enrolled.
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Kidney injury after heart surgery: a cost analysis
Knowledge-focused CancelledThis study aimed to compare costs and health outcomes for heart surgery patients who developed acute kidney injury versus those who did not. Researchers planned to review medical records from UK hospitals over a 10-year period. The study was withdrawn before enrolling any partici…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC